Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer. Ann Oncol 2008;19: 724-8.Santini D,Perrone G,Vincenzi B. Human equilibrative nucleoside transporter 1(hENT1)protein is associated with short survival in resected ampullary ...
Background: Tumor overexpression of excision repair cross-complementing gene-1 (ERCC1) may be associated with decreased survival in patients with pancreas adenocarcinoma (PAC). Human equilibrative nucleoside transporter-1 (hENT1) and ribonucleoside reductase subunits M1 and M2 (RRM1 and RRM2...
Equilibrative nucleoside transporters (ENTs), which facilitate cross-membrane transport of nucleosides and nucleoside-derived drugs, play an important role in the salvage pathways of nucleotide synthesis, cancer chemotherapy, and treatment for virus infections. Functional characterization of ENTs at the ...
Fisher SB,Patel SH,Bagci P,et al.An analysis of human equilibrative nucleosidetransporter-1,ribonucleoside reductase subunit M1,ribonucleoside reductase subunit M2,and excision repair cross-comple menting gene-1expression in patients with resectedpancreas adenocarcinoma: implications for. . 2012...
A Sandwich ELISA, Double Antibody ELISA kit for the detection of Homo sapiens, Human, Equilibrative nucleoside transporter 1, Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter, Equilibrative NBMPR-sensitive nucleoside tran
Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons Transgenic mice that express human equilibrative nucleoside transporter subtype 1 (hENT1) under the control of a neuron-specific enolase promoter have been... FE Parkinson,W Xiong,CR Zamzow,... - 《Journal of ...
Although two different nucleoside analogs were used to measure drug cytotoxicity and uptake, they are both predominantly transported by the human equilibrative nucleoside transporter 1 (hENT1), which is thought to be the predictive biomarker responsible for the therapeutic efficacy of nucleoside analog ...
Human equilibrative nucleoside transporter 1 is not predictive for gemcitabine efficacy in advanced pancreatic cancer: Translational results from the AIO-PK0104 phase III study with the clone SP120 rabbit antibody 喜欢 0 阅读量: 20 作者:Isaacson,Mann,Kruger,Kirchner,Bartosiewicz,Haas,Raponi,Ormanns,...
Summary: Thirtynine genetic variations, including thirty novel ones, were found in the human SLC29A1 gene, which encodes equilibrative nucleoside transporter 1, from 256 Japanese cancer patients administered gemcitabine. The found novel variations included –8166G > A, –8110A > G, –7947G >...
BACKGROUND: Tumor expression of excision cross-complementing gene-1 (ERCC1), human equilibrative nucleoside transporter 1 (hENT1), ribonucleotide reductase subunit M1 (RRM1), and ribonucleotide reductase subunit M2 (RRM2), is associated with the efficacy of platinum and gemcitabine chemotherapy....